RIMAG GROUP (02522) continued its upward momentum with another surge of nearly 14%. As of press time, the stock was up 11.61% to HK$22.2, with trading volume reaching HK$1.016 billion.

On the news front, RIMAG GROUP will convene a board meeting on August 18 to approve its interim results. The company previously forecasted first-half revenue of RMB 450-480 million, representing a year-on-year increase of approximately 8.77% to 16.03%. Net profit is expected to range from RMB 14.5 million to RMB 16.5 million, marking a substantial year-on-year growth of approximately 1,350% to 1,550%.

The board attributed the revenue increase primarily to the growth in customer base and the number of services delivered by the company. The significant rise in net profit was mainly due to the aforementioned revenue growth during the period compared to the same period in 2024, coupled with a reduction in administrative expenses.

Previously, securities analysts noted that RIMAG GROUP is a leading domestic medical imaging service provider with a steady expansion pace. In the AI era, the company is developing comprehensive smart imaging solutions and establishing pathways for data monetization and application. The long-term development potential of the company remains promising.